Vinge has advised Edastra AB in connection with the company’s capital procurement. Edastra is an investment company which primarily invests in digitalisation and sustainability.
Through the rights issue of units, consisting of shares and warrants, and the exercised over-allotment issue, Isofol will receive approximately SEK 84 million and may receive an additional maximum of approximately SEK 110 million upon exercise of all warrants at the highest subscription price.